Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pu (Q46909246)
Jump to navigation
Jump to search
scientific article published in October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pu |
scientific article published in October 2007 |
Statements
Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study) (English)
Rudolf Speich
Guido Domenighetti
Thomas Geiser
Thierry Rochat
Lars Huber
Ursula Treder